Dopamine and Sensorimotor Function in Stuttering

Recruiting now · Phase 1 · Has a placebo group

Conditions studied: Stuttering, Adult

In brief

This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.

Key facts

Study ID

NCT07215884

Run by

University of California, San Francisco

People needed

40

Starts

2025-09-30

Expected to finish

2026-06-30

Last updated by the study team

2025-10-14

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• native speakers of American English
• for adults who stutter, presence of stuttering will be confirmed, with onset before age 6 years
• Normal hearing
• Ages of 18 to 65 years
• healthy adults without hearing-language difficulties

You may not qualify if…

• self-reported speech-language-hearing difficulties other than stuttering
• self-reported neurological or psychological problems
• other medications (drugs that affect dopaminergic system and/or benzodiazepines)

Where it is running

• Biomagentic Imaging Lab — San Francisco, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.